HITI - High Tide Inc.
NASDAQ
->
Healthcare
->
Pharmaceutical Retailers
Calgary,
Canada
Type: Equity
HITI price evolution
HITI
| (in millions $) | 1 May 2024 | 31 Jan 2024 | 31 Aug 2023 | 30 Jul 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $4.48 | $7.57 | $9.71 | $9.72 |
| Inventory | $25.44 | $25.97 | $26.62 | $27.2 |
| Total current assets | $65.28 | $68.64 | $67.28 | $61.84 |
| Long term investments | ||||
| Property, plant & equipment | $60.48 | $57.78 | $55.25 | $57.95 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $227.31 | $233.4 | $265.16 | $268.09 |
| Current liabilities | ||||
| Accounts payable | $6.18 | $8.35 | $5.5 | $6.18 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $57.79 | $58.14 | $58.19 | $56.39 |
| Long term debt | $28.67 | $40.33 | $37.25 | $39.62 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $89.66 | $101.84 | $106 | $109.15 |
| Shareholders' equity | ||||
| Retained earnings | -$192.97 | -$193.19 | -$163.88 | -$160.38 |
| Other shareholder equity | $4.71 | $5.97 | $4.53 | $4.21 |
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 1 Dec 2021 | 30 Nov 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $14.01 | $5.6 | ||
| Short term investments | ||||
| Net receivables | $7.57 | $8.2 | $7.45 | $2.13 |
| Inventory | $25.97 | $23.41 | $17.04 | $4.24 |
| Total current assets | $68.64 | $64.06 | $46.29 | $14.34 |
| Long term investments | ||||
| Property, plant & equipment | $57.78 | $62 | $52.74 | $9.73 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $37.59 | |||
| Total investments | ||||
| Total assets | $233.4 | $274.74 | $246.22 | $51.93 |
| Current liabilities | ||||
| Accounts payable | $8.35 | $7.67 | $18.53 | $4.78 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $58.14 | $59.94 | $40.79 | $20.43 |
| Long term debt | $40.33 | $43.17 | $43.15 | $28.39 |
| Total noncurrent liabilities | $22.78 | |||
| Total debt | ||||
| Total liabilities | $101.84 | $118.39 | $99.01 | $43.21 |
| Shareholders' equity | ||||
| Retained earnings | -$193.19 | -$152.6 | -$77.07 | -$25.56 |
| Other shareholder equity | $5.97 | $6.38 | $0.21 | $6.57 |
| Total shareholder equity | ||||
| (in millions $) | 30 Oct 2022 | 30 May 2022 | 1 May 2022 | 1 Dec 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $81.03 | |||
| Cost of revenue | ||||
| Gross Profit | $22.69 | |||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $29.41 | |||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | -$0.8 | |||
| Interest expense | -$1.82 | |||
| Net income | ||||
| Net income | -$8.3 | |||
| Income (for common shares) | ||||
| (in millions $) | 1 Dec 2021 | 30 Nov 2020 | 30 Nov 2019 | 1 Dec 2018 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $181.12 | $61.94 | $23.55 | $8.75 |
| Cost of revenue | ||||
| Gross Profit | $63.98 | $22.92 | $8.51 | $3.11 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $77.83 | $22.35 | $23.5 | $6.7 |
| Operating income | $0.59 | -$14.95 | ||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | -$0.73 | $0.17 | -$0.53 | -$1.5 |
| Interest expense | -$18.15 | $7.45 | $2.32 | -$0.04 |
| Net income | ||||
| Net income | -$35.72 | -$4.73 | -$19.78 | -$4.52 |
| Income (for common shares) | ||||
| (in millions $) | 31 Aug 2022 | 30 May 2022 | 3 Mar 2022 | 1 Dec 2021 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$7.32 | -$4.52 | -$2.06 | -$28.49 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $15.41 | $9.32 | -$0.29 | $37.81 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $4.31 | $0.98 | -$3.93 | $6.49 |
| (in millions $) | 1 Dec 2021 | 30 Nov 2020 | 30 Nov 2019 | 1 Dec 2018 |
|---|---|---|---|---|
| Net income | -$4.73 | -$19.78 | ||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $6.58 | -$11.16 | ||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$28.49 | -$2.46 | -$12.73 | -$4.23 |
| Financing activities | ||||
| Dividends paid | -$1.16 | |||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $37.81 | $0.87 | $18.33 | $20.14 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $6.49 | $5 | -$5.56 | $7.13 |
News
Fundamentals
| Market cap | $158.69M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 78.56M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.13 |
| Quick ratio | 0.69 |